Cargando…
Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
Non-human primate (NHP)-derived adenoviruses have formed a valuable alternative for the use of human adenoviruses in vaccine development and gene therapy strategies by virtue of the low seroprevalence of neutralizing immunity in the human population. The more recent use of several human adenoviruses...
Autores principales: | Bots, Selas T.F., Hoeben, Rob C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404033/ https://www.ncbi.nlm.nih.gov/pubmed/32650405 http://dx.doi.org/10.3390/ijms21144821 |
Ejemplares similares
-
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
por: Hensen, Lobke C.M., et al.
Publicado: (2020) -
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates
por: Bots, Selas T.F., et al.
Publicado: (2022) -
Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C
por: Bots, Selas T. F., et al.
Publicado: (2022) -
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus ‘GoraVir’ in Cultured Pancreatic Cancer Cells
por: Bots, Selas T. F., et al.
Publicado: (2023) -
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)